NEUROCLEAR Trademark

Trademark Overview

On Monday, November 5, 2018, a trademark application was filed for NEUROCLEAR with the United States Patent and Trademark Office. The USPTO has given the NEUROCLEAR trademark a serial number of 88182405. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by BioSig Technologies, Inc.. The NEUROCLEAR trademark is filed in the Medical Instrument Products category with the following description:

medical device, apparatus, and instruments that make use of signal processing technology for targeted nerve stimulation and peripheral nerve stimulation to treat sympathetic nervous system disorders, cardiovascular diseases, nephrological diseases, cognitive disorders, and chronic pain
neuroclear

General Information

Serial Number88182405
Word MarkNEUROCLEAR
Filing DateMonday, November 5, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Pseudo MarkNEURON CLEAR
Goods and Servicesmedical device, apparatus, and instruments that make use of signal processing technology for targeted nerve stimulation and peripheral nerve stimulation to treat sympathetic nervous system disorders, cardiovascular diseases, nephrological diseases, cognitive disorders, and chronic pain

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, November 20, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNEUROCLEAR TECHNOLOGIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestport, CT 06880
Party NameNEUROCLEAR TECHNOLOGIES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLOS ANGELES, CA 90025
Party NameBioSig Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90025

Trademark Events

Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, February 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 14, 2021SOU EXTENSION 3 GRANTED
Tuesday, December 14, 2021SOU EXTENSION 3 FILED
Tuesday, December 14, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 27, 2021CORRECTED NOA E-MAILED
Tuesday, July 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 26, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 23, 2021SOU EXTENSION 2 FILED
Monday, July 26, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, June 23, 2021DIVISIONAL REQUEST RECEIVED
Saturday, July 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 23, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, June 23, 2021SOU TEAS EXTENSION RECEIVED
Friday, December 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 23, 2020SOU EXTENSION 1 GRANTED
Wednesday, December 23, 2020SOU EXTENSION 1 FILED
Wednesday, December 23, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2020EXAMINER'S AMENDMENT ENTERED
Monday, March 23, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 23, 2020EXAMINERS AMENDMENT E-MAILED
Monday, March 23, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, September 30, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 30, 2019NON-FINAL ACTION E-MAILED
Monday, September 30, 2019NON-FINAL ACTION WRITTEN
Sunday, September 15, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 20, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, August 5, 2019ASSIGNED TO LIE
Wednesday, July 31, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 15, 2019NON-FINAL ACTION E-MAILED
Friday, February 15, 2019NON-FINAL ACTION WRITTEN
Saturday, February 9, 2019ASSIGNED TO EXAMINER
Tuesday, November 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 8, 2018NEW APPLICATION ENTERED

Related Keywords

neuroclear nerve stimulation disorders diseases chronic pain nervous system cognitive sympathetic